皮质缓解缓解与耐药性有关
Yonatan Serlin1, Hamza Imtiaz2, Tamir Avigdor3
1Neurophysiology of Epilepsy Unit, NINDS, National Institutes of Health, Bethesda, MD, USA; Department of Medical Neuroscience and the Brain Repair Center, Dalhousie University, Faculty of Medicine, Halifax, NS, Canada.
EBioMedicine
|May 29, 2025
概括
通过脑电图 (EEG) 检测到的慢波发作事件 (PSWE) 在患者中更为常见,特别是在焦点患者中. 长时间的PSWE可能预测耐药性 (DRE) 和不良的外科手术结果.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
- 生物标志物发现发现
背景情况:
- 缓冲性慢波事件 (PSWEs) 是EEG段,其中位功率频率低于6Hz,持续时间≥5秒.
- 在此之前,PSWE已经在经历第一次发作的患者中显示出的预测价值.
- 这项研究调查了PSWE作为耐药性 (DRE) 生物标志物的流行,局部和潜力.
研究的目的:
- 在大型,独立的EEG数据集中评估PSWE的流行和局部.
- 探索PSWE作为潜在生物标志物的实用性,用于识别耐药性 (DRE).
- 评估PSWE与病病因,局部和治疗反应之间的关联.
主要方法:
- 一项探索性分析涉及来自寺大学EEG体的1064名参与者,将患者与对照者进行比较.
- 一项验证分析使用了来自波恩大学的95名参与者的独立队列,包括药物反应性和DRE患者.
- 分析了EEG数据,以量化在PSWE中花费时间的比例和它们的位置.
主要成果:
- 与没有的患者相比,患有的患者的PSWE显著更长时间 (P < 0.0001).
- 长期的PSWE在焦点中最为突出,特别是在叶参与的情况下 (P = 0.005).
- 患有DRE的患者表现出长期的PSWE,与折射性风险增加相关 (OR = 1.9) 并在验证中得到证实 (AUC = 0.829).
- 在手术前对手术结果不佳的患者 (Engel IB-IV) 的脑电图显示,与成功的结果 (Engel IA) 相比,PSWE延长了.
结论:
- 在两个队列中对1159个EEG的分析证实PSWE在焦点中更为普遍和持续.
- 长时间的PSWE可能作为耐药性的预测生物标志物 (DRE).
- PSWE可能表明患者缺乏治疗反应.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
151
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
151
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
275
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
275
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
358
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
358
01:24Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
01:14Antiepileptic Drugs: Glutamate Antagonists
302
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
302
01:17Antiepileptic Drugs: Calcium Channel Blockers
350
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
350